Abstract
We report here a mentally retarded 32-month-old boy whose initial diagnosis was Angelman syndrome based on his clinical features. Cytogenetic studies showed a normal karyotype. Due to an elevated level of serum creatine kinase activity, we performed analyses to rule out a myopathic process. Although the electromyogram was normal, a few scattered necrotic fibres were seen in the muscle biopsy. DNA and dystrophin studies revealed an in-frame deletion in the 5′ region of the dystrophin gene and an abnormal form of the protein product, consistent with a diagnosis of dystrophinopathy. We cannot totally rule out the possibility that this boy has the two separate conditions.
Similar content being viewed by others
Abbreviations
- AS :
-
Angelman syndrome
- BMD :
-
Becker muscular dystrophy
- CK :
-
creatine kinase
- DMD :
-
Duchenne muscular dystrophy
References
Beggs AH, Koenig M, Boyce FM, et al (1990) Detection of 98% of the DMD/BMD deletions by PCR. Hum Genet 86: 45–48
Beggs AH, Hoffman EP, Snyder JR, Arahata K, Specht L, Shapiro F, Angelini C, Sugita H, Kunkel LM (1991) Exploring the molecular basis for variability among patients with Becker Muscular Dystrophy: dystrophin gene and protein studies. Am J Hum Genet 49: 54–67
Bushby KMD, Gadner-Medwin D, Nicholson LVB, Johnson MA, Haggerty ID, Cleghorn NJ, Harris JB (1993) The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic protein abnormalities. J Neurol 240: 105–112
Chamberlain JS, Gibbs RA, Ranier JS, et al (1990) Multiplex PCR for diagnosis of Duchenne muscular dystrophy. In: Innis MA, Gelfand DH, Sninski JJ, White TJ (eds) PCR protocols: a guide to methods and applications. Academic Press, San Diego, pp 272–281
Dubowitz V, Brooke MH (1973) Muscle biopsy: a modern approach. In: Major problems in neurology. W. B. Saunders, Philadelphia, pp 5–33
Gold RG, Kress W, Meurers B, Meng G, Reichmann H, Müller CR (1992) Brief communication: Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis. Muscle and Nerve 15: 214–218
Imaizumi K, Takada F, Kuroki Y, et al (1990) Cytogenetic and molecular study of the Angelman syndrome. Am J Med Genet 35: 314–318
McDonald TD, Medori R, Younger DS, Chang HW, Minetti C, Uncini A, Bonilla E, Hays A, Lovelace R (1991) Becker muscular dystrophy or spinal muscular atrophy?—Dystrophyn studies resolve conflicting results of electromyography and muscle biopsy. Neuromuscular Disorders 1, 3: 195–200
Muntoni F, Mattedu A, Cianchetti C et al (1993) Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy. J Neurol Neuros Psych 56: 26–31
Nicholson LVB, Davison K, Falkous G, Harwood C, O'Donnell E, Slater C, Harris JB (1989) Dystrophin in skeletal muscle: I. Western blot analysis using a monoclonal antibody. J Neurol Sci 94: 125–136
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Colomer, J., Gallano, P., Tizzano, E. et al. Severe mental retardation in a young boy with an in-frame deletion in the dystrophin gene. Eur J Pediatr 153, 492–494 (1994). https://doi.org/10.1007/BF01957003
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957003